ClavystBio: A life science investment firm funding early-stage ventures in biotech, medTech, and more.
Location
Singapore, SG
Founded
2021
ClavystBio is a life science investment firm focused on early-stage ventures in biotech, medTech, and digital health sectors. Based in Singapore, the firm invests in and partners with innovators, entrepreneurs, and founders to launch and grow global companies. ClavystBio's venture building approach involves active incubation and investment in promising scientific breakthroughs.
The firm's portfolio includes Paratus Sciences, which has raised $100 million. ClavystBio emphasizes fostering company creation and growth, backing great science, and enabling novel solutions. They forge public and private partnerships to accelerate talent development and offer a trusted partner approach to their portfolio companies.
ClavystBio - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A1 (50.0%)
Series D1 (50.0%)
Stage Mix
Series A 50%Series D 50%
Concentration shown as share of disclosed investments by stage.
